US Stock MarketDetailed Quotes
BDTX Black Diamond Therapeutics
- 6.200
- +0.290+4.91%
Trading Jul 23 11:37 ET
348.86MMarket Cap-3734P/E (TTM)
6.270High5.887Low100.52KVolume5.890Open5.910Pre Close620.72KTurnover0.23%Turnover RatioLossP/E (Static)56.27MShares7.66052wk High3.34P/B272.99MFloat Cap1.62052wk Low--Dividend TTM44.03MShs Float46.250Historical High--Div YieldTTM6.49%Amplitude1.180Historical Low6.175Avg Price1Lot Size
About Black Diamond Therapeutics Company
Black Diamond Therapeutics, Inc. is a precision oncology medicine company, which engages in discovery and development of small molecule, masterkey therapies. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.
Company Profile
SymbolBDTX
Company NameBlack Diamond Therapeutics
Listing DateJan 30, 2020
Issue Price19.00
Founded2014
CEODr. Mark A. Velleca, M.D.
MarketNASDAQ
Employees54
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressOne Main Street,14th floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-252-0848
Company Executives
- Name
- Position
- Salary
- Dr. Mark A. Velleca, M.D.
- Chairman of the Board, President and Chief Executive Officer
- 2.95M
- Brent Hatzis-Schoch, Esq.
- Chief Operating Officer and General Counsel
- --
- Dr. Fang Ni
- Chief Business Officer and Chief Financial Officer
- 1.49M
- Melanie Morrison
- Chief Development Officer
- --
- Elizabeth L. Montgomery
- Chief People Officer
- --
- Sergey Yurasov, M.D.,Pd.D
- Chief Medical Officer
- 1.23M
- Elizabeth Buck, PhD
- Chief Scientific Officer
- --
- Erika Jones
- Senior Vice President, Finance, Corporate Controller and Principal Accounting Officer
- --
- Dr. Samarth Kulkarni, PhD
- Lead Independent Director
- 59.35K
- Dr. Kapil Dhingra, M.B.B.S.
- Independent Director
- 109.35K
- Shannon Campbell, PhD
- Independent Director
- --
- Dr. Prakash Raman, PhD
- Independent Director
- --
- Dr. Ali Behbahani, M.B.A.,M.D.
- Independent Director
- 68.14K
- Dr. Garry E. Menzel, PhD
- Independent Director
- 75.35K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg